1. Adelaide Research & Scholarship
  2. Schools and Disciplines
  3. School of Medicine
  4. Medicine
  5. Medicine publications
Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/89999
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCarroll, R.-
dc.contributor.authorCoates, P.-
dc.date.issued2015-
dc.identifier.citationKidney International, 2015; 87(2):277-279-
dc.identifier.issn0085-2538-
dc.identifier.issn1523-1755-
dc.identifier.urihttp://hdl.handle.net/2440/89999-
dc.descriptionCommentary-
dc.description.abstractIn the study by Jackson et al., 50 subjects were given plasma exchange and low-dose intravenous immunoglobulin to desensitize for live-donor kidney transplantation, and those deemed to have high immunological risk were also given rituximab. Transplant outcomes were similar between the two groups even though the rituximab group had higher immunological risk. These results suggest that rituximab may be helpful when added to 'standard' desensitization protocols, but definitive trials are still lacking in this area.-
dc.description.statementofresponsibilityRobert Carroll and P Toby Coates-
dc.language.isoen-
dc.publisherNature Publishing Group-
dc.rights© 2015 International Society of Nephrology-
dc.source.urihttp://dx.doi.org/10.1038/ki.2014.365-
dc.subjectHumans-
dc.subjectIsoantibodies-
dc.subjectHLA Antigens-
dc.subjectKidney Transplantation-
dc.subjectFemale-
dc.subjectMale-
dc.subjectRituximab-
dc.titleDoes rituximab help in HLA desensitization for kidney transplantation?-
dc.typeJournal article-
dc.identifier.doi10.1038/ki.2014.365-
pubs.publication-statusPublished-
dc.identifier.orcidCarroll, R. [0000-0002-6238-026X]-
Appears in Collections:Aurora harvest 2
Medicine publications

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.